Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: Lancet Digit Health. 2023 Oct;5(10):e668–e678. doi: 10.1016/S2589-7500(23)00109-7

Figure 1: Trial profile.

Figure 1:

The intention-to-treat population included all randomly assigned patients who completed at least one post-baseline assessment (ie, any or all of the 4-week, 8-week, or 12-week follow-up assessments).